Optimization of Heart Failure Treatment by Heart Rate Reduction.
Cardiovascular comorbidities
Chronic heart failure
Heart rate
Heart rhythm
Ivabradine
Patient outcomes
Journal
International journal of heart failure
ISSN: 2636-1558
Titre abrégé: Int J Heart Fail
Pays: Korea (South)
ID NLM: 101775659
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
23
10
2019
accepted:
12
11
2019
entrez:
20
10
2022
pubmed:
9
12
2019
medline:
9
12
2019
Statut:
epublish
Résumé
Heart failure (HF) treatment should be optimized in addition to guideline-directed and recommended drugs to achieve an appropriate heart rate (i.e. 50-60 bpm) by ivabradine in patients with a heart rate >70 bpm in sinus rhythm and with an ejection fraction ≤35%. Heart rate reduction was to reduce cardiovascular death and HF hospitalization dependent on baseline resting heart rate. In particular in patients at a heart rate >75 bpm, a reduction in cardiovascular death, all-cause death, HF death, HF hospitalization and all-cause hospitalization has been observed. The optimal heart rate achieved appears to be between 50-60 bpm, if well tolerated as in these patients the lowest event rate is observed on treatment. Heart rate reduction is, therefore, a treatable risk factor in chronic HF. Observational studies support the concept that it is a risk indicator in other cardiovascular and non-cardiovascular conditions. Whether heart rate reduction is also modifying risk in other conditions than chronic HF should be explored in prospective clinical trials.
Identifiants
pubmed: 36263079
doi: 10.36628/ijhf.2019.0009
pmc: PMC9536732
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1-11Informations de copyright
Copyright © 2020. Korean Society of Heart Failure.
Déclaration de conflit d'intérêts
Conflict of Interest: MB received grants and honoraria from Servier and was Executive Boar Member of the SHIFT trial.
The other authors have no financial conflicts of interest.
Références
Am J Cardiol. 2016 Dec 15;118(12):1948-1953
pubmed: 27780557
Int J Cardiol. 2010 Apr 30;140(3):279-86
pubmed: 19095316
Ann Intern Med. 2009 Jun 2;150(11):784-94
pubmed: 19487713
Am J Cardiol. 2008 Mar 15;101(6):865-9
pubmed: 18328855
Clin Pharmacol Ther. 1998 Aug;64(2):192-203
pubmed: 9728900
Drugs. 2004;64(16):1757-65
pubmed: 15301560
Int J Cardiol. 2013 Dec 10;170(2):182-8
pubmed: 24225201
JAMA. 2000 Mar 8;283(10):1295-302
pubmed: 10714728
Am Heart J. 2013 Feb;165(2):216-25
pubmed: 23351825
Am J Cardiol. 2015 Dec 15;116(12):1890-7
pubmed: 26508709
Am J Cardiol. 2014 Feb 1;113(3):497-503
pubmed: 24332674
Eur J Heart Fail. 2017 Oct;19(10):1230-1241
pubmed: 28627045
Am Heart J. 1987 Jun;113(6):1489-94
pubmed: 3591616
Am J Hypertens. 2009 Feb;22(2):151-5
pubmed: 19151693
Circulation. 1992 May;85(5):1743-50
pubmed: 1572031
Eur J Heart Fail. 2004 Aug;6(5):663-8
pubmed: 15302016
Eur J Heart Fail. 2014 Jan;16(1):103-11
pubmed: 24453099
Clin Res Cardiol. 2013 Jan;102(1):11-22
pubmed: 22575988
Circulation. 2001 Mar 13;103(10):1428-33
pubmed: 11245648
Heart Fail Rev. 2013 Mar;18(2):107-22
pubmed: 22581217
Int J Cardiol. 2016 Aug 15;217:7-11
pubmed: 27167103
Circ Heart Fail. 2013 May;6(3):403-10
pubmed: 23599310
Eur Heart J. 2002 Aug;23(16):1301-8
pubmed: 12175667
Eur J Heart Fail. 2008 Jun;10(6):550-5
pubmed: 18486549
Diabetes Care. 2008 Feb;31(2):335-9
pubmed: 17959868
Hypertension. 2010 Feb;55(2):567-74
pubmed: 20038750
Lancet. 2010 Sep 11;376(9744):875-85
pubmed: 20801500
Lancet. 2010 Sep 11;376(9744):886-94
pubmed: 20801495
J Am Coll Cardiol. 2012 May 29;59(22):1938-45
pubmed: 22617188
Eur J Heart Fail. 2014 Apr;16(4):426-34
pubmed: 24504937
Eur J Heart Fail. 2016 Sep;18(9):1182-9
pubmed: 27210035
Eur J Heart Fail. 2015 May;17(5):518-26
pubmed: 25801408
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
J Intern Med. 2015 Jul;278(1):38-49
pubmed: 25431275
Eur Respir J. 2013 Aug;42(2):341-9
pubmed: 23143550
Circulation. 2002 Oct 22;106(17):2194-9
pubmed: 12390947
Eur J Heart Fail. 2013 Aug;15(8):885-91
pubmed: 23460732
Eur J Heart Fail. 2013 Sep;15(9):1044-52
pubmed: 23696612
Eur J Heart Fail. 2015 Dec;17(12):1294-301
pubmed: 26377342
N Engl J Med. 2014 Sep 18;371(12):1091-9
pubmed: 25176136
Eur J Heart Fail. 2013 Nov;15(11):1296-303
pubmed: 23803951
Eur J Heart Fail. 2014 Jul;16(7):810-6
pubmed: 24961493
JACC Heart Fail. 2013 Dec;1(6):488-96
pubmed: 24622000
Adv Ther. 2015 Feb;32(2):108-19
pubmed: 25700807
Am Heart J. 1991 Jan;121(1 Pt 1):172-7
pubmed: 1985358
Eur J Heart Fail. 2017 Feb;19(2):250-252
pubmed: 27917598
Eur J Clin Pharmacol. 2005 Jul;61(5-6):445-51
pubmed: 15940531
Lancet. 2008 Sep 6;372(9641):807-16
pubmed: 18757088
Eur J Heart Fail. 2014 Jan;16(1):76-85
pubmed: 23928650
Lancet. 2008 Sep 6;372(9641):817-21
pubmed: 18757091
Clin Investig. 1992 May;70(5):421-5
pubmed: 1600353